Discovery of Selective Inhibitor and Degrader of Mutant PI3Kα

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(03): 0305
DOI: 10.1055/s-0042-1752402

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nadine Kuhl (MSD)

,

Ferdinand H. Lutter (Janssen Pharmaceutica)

inavolisib - PI3K inhibitor - breast cancer - Ullmann coupling

Article published online:
13 February 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany